MRI Interventions (OTC: MRIC) is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI guidance. The company’s products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Its ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases and its ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. For more information, visit the company’s website at www.mriinterventions.com